ENLYTE

Mitchell Pharmacy Solutions Drug Trends Report

The State of Pharmacy Drug Trends in Workers' Comp Today

To provide the most accurate view of continued trends in pharmacy management, Enlyte analyzes drug utilization and spending trends in workers’ comp on an annual basis. This year’s series reflects on the trends our clients experienced in 2021, providing an overall picture of both in- and out-of-network prescriptions in a four-part series.

Part One: Evaluating Retail and Mail Order Prescriptions | Part Two: Evaluating In-Network and Out-Of-Network Trends


Part One: Evaluating Retail and Mail Order Prescriptions

The COVID outbreak created countless challenges that have continued to carry on through 2021 and now into 2022. The way we work has been influenced forever, and as such workers’ comp has seen a shift in claim volumes and in conjunction pharmacy trends in both retail and mail-order channels.


 

Drug Trends: Opioid Trends

Join Tom Kerr, Mitch Freeman and Nikki Wilson in a deeper dive of the annual drug trends report as they discuss the continued decline of opioid usage in 2021 even while other classes rose.

Drug Trends: Top 10 Therapeutic Classes

In 2021, 6 of the top 10 therapeutic classes experienced increased utilization. As part of our drug trends series, we’ll break out the categories with the biggest cost and utilization changes.

Part Two: Evaluating In-Network and Out-Of-Network Trends

This analysis features trends experienced within our combined in- and out-of-network channels to address the total view of prescription activity. From a percentage perspective, in-network still represents the majority with over 80% of the prescriptions filled, with out-of-network representing less than 20%, indicating pharmacy management programs continue to positively influence prescription utilization.

Drug Trends: Taking a Look at the Total View of the Top 10 Classes Part One

Join us for our continued discussion of the top therapeutic classes as we look at combined in-network and out-of-network data. In the first half of our discussion, we’ll focus on how declining opioid use has led to increases in utilization of other classes. To learn more, watch this video.

Drug Trends: Taking a Look at the Total View of the Top 10 Classes Part Two

In our continued discussion of the top therapeutic classes, we look at combined in-network and out-of-network data. In the second half of our discussion, we’re digging deeper into cost per script, scripts per claim, and cost per claim. To learn more, watch this video.